These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


782 related items for PubMed ID: 25516099

  • 1. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F, Cheng T, Dong Q, Wei R, Zhang Z, Luo D, Ma X, Wang S, Gao Q, Ma D, Zhu X, Xi L.
    Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
    [Abstract] [Full Text] [Related]

  • 2. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.
    Liu Y, Lan X, Wu T, Lang J, Jin X, Sun X, Wen Q, An R.
    Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147
    [Abstract] [Full Text] [Related]

  • 3. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V.
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [Abstract] [Full Text] [Related]

  • 4. Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer.
    Han Z, Xiao Y, Wang K, Yan J, Xiao Z, Fang F, Jin Z, Liu Y, Sun X, Shen B.
    J Nucl Med; 2018 Nov; 59(11):1686-1691. PubMed ID: 29777004
    [Abstract] [Full Text] [Related]

  • 5. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
    Yu F, Lü ML, Zhang XP, Fu D, Hou M, Cai HD, Li D, Wang J, Yuan XY, Lü ZW, Dong F.
    Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
    [Abstract] [Full Text] [Related]

  • 6. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R.
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [Abstract] [Full Text] [Related]

  • 7. Comparison of biological properties of 99mTc-labeled cyclic RGD Peptide trimer and dimer useful as SPECT radiotracers for tumor imaging.
    Zhao ZQ, Yang Y, Fang W, Liu S.
    Nucl Med Biol; 2016 Nov; 43(11):661-669. PubMed ID: 27556955
    [Abstract] [Full Text] [Related]

  • 8. 99mTc-labeling and evaluation of a HYNIC modified small-molecular inhibitor of prostate-specific membrane antigen.
    Xu X, Zhang J, Hu S, He S, Bao X, Ma G, Luo J, Cheng J, Zhang Y.
    Nucl Med Biol; 2017 May; 48():69-75. PubMed ID: 28273495
    [Abstract] [Full Text] [Related]

  • 9. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
    von Guggenberg E, Behe M, Behr TM, Saurer M, Seppi T, Decristoforo C.
    Bioconjug Chem; 2004 May; 15(4):864-71. PubMed ID: 15264875
    [Abstract] [Full Text] [Related]

  • 10. Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.
    Zhao X, Wang N, Ren X, Zhang J, Wang J, Han J, Jia L, Liu Y, Zhang Z.
    J Nucl Med; 2014 Jun; 55(6):1008-16. PubMed ID: 24744447
    [Abstract] [Full Text] [Related]

  • 11. [99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor.
    Kaihani S, Sadeghzadeh N, Abediankenari S, Abedi SM.
    Ann Nucl Med; 2022 Nov; 36(11):976-985. PubMed ID: 36097232
    [Abstract] [Full Text] [Related]

  • 12. Clinical translation of a PSMA inhibitor for 99mTc-based SPECT.
    Ferro-Flores G, Luna-Gutiérrez M, Ocampo-García B, Santos-Cuevas C, Azorín-Vega E, Jiménez-Mancilla N, Orocio-Rodríguez E, Davanzo J, García-Pérez FO.
    Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
    [Abstract] [Full Text] [Related]

  • 13. Radiolabeling and biological evaluation of the GX1 and RGD-GX1 peptide sequence for angiogenesis targeting.
    Oliveira EA, Faintuch BL.
    Nucl Med Biol; 2015 Feb; 42(2):123-30. PubMed ID: 25311749
    [Abstract] [Full Text] [Related]

  • 14. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
    Dong C, Zhao H, Yang S, Shi J, Huang J, Cui L, Zhong L, Jin X, Li F, Liu Z, Jia B, Wang F.
    Mol Pharm; 2013 Aug 05; 10(8):2925-33. PubMed ID: 23768172
    [Abstract] [Full Text] [Related]

  • 15. (99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.
    Ananias HJ, Yu Z, Dierckx RA, van der Wiele C, Helfrich W, Wang F, Yan Y, Chen X, de Jong IJ, Elsinga PH.
    Mol Pharm; 2011 Aug 01; 8(4):1165-73. PubMed ID: 21699202
    [Abstract] [Full Text] [Related]

  • 16. Kit formulated asialoglycoprotein receptor targeting tracer based on copolymer for liver SPECT imaging.
    Liu C, Guo Z, Zhang P, Song M, Zhao Z, Wu X, Zhang X.
    Nucl Med Biol; 2014 Aug 01; 41(7):587-93. PubMed ID: 24815356
    [Abstract] [Full Text] [Related]

  • 17. Preliminary application of micro-SPECT/CT imaging by 99m Tc-tricine-EDDA-HYNIC-c-Met for non-small-cell lung cancer.
    Zhang Y, Meng L, Li B, Tan H, Lin QY, Cheng D, Shi H.
    Chem Biol Drug Des; 2019 Apr 01; 93(4):447-453. PubMed ID: 30381892
    [Abstract] [Full Text] [Related]

  • 18. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
    Yang W, Luo D, Wang S, Wang R, Chen R, Liu Y, Zhu T, Ma X, Liu R, Xu G, Meng L, Lu Y, Zhou J, Ma D.
    Clin Cancer Res; 2008 Sep 01; 14(17):5494-502. PubMed ID: 18765541
    [Abstract] [Full Text] [Related]

  • 19. [99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers.
    Vats K, Chakraborty A, Rakshit S, Damle A, Sarma HD, Satpati D.
    Nucl Med Biol; 2023 Sep 01; 118-119():108331. PubMed ID: 36933456
    [Abstract] [Full Text] [Related]

  • 20. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.
    Xia X, Feng H, Li C, Qin C, Song Y, Zhang Y, Lan X.
    Nucl Med Biol; 2016 Jan 01; 43(1):89-96. PubMed ID: 26466867
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.